Low prevalence of autoantibodies to CENP-H, -I, -K, -L, -M, -N, -T and -U in a Japanese cohort of anti-centromere positive samples

References

• Tan, E.M., Rodnan, G.P., Garcia, I., Moroi, Y., Fritzler, M.J., Peebles, C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 1980, 23, 617–625.
   PubMed Web of Science ®Google Scholar
• Vlachoyiannopoulos, P.G., Drosos, A.A., Wiik, A., Moutsopoulos, H.M. Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 1993, 32, 297–301.
   PubMedGoogle Scholar
• Nakano, M., Ohuchi, Y., Hasegawa, H., Kuroda, T., Ito, S., Gejyo, F. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 2000, 27, 1403–1407.
   PubMed Web of Science ®Google Scholar
• Katano, K., Kawano, M., Koni, I., Sugai, S., Muro, Y. Clinical and laboratory features of anticentromere antibody positive primary Sjögren’s syndrome. J Rheumatol 2001, 28, 2238–2244.
   PubMed Web of Science ®Google Scholar
• Fritzler, M.J., Rattner, J.B., Luft, L.M., Edworthy, S.M., Casiano, C.A., Peebles, C., Mahler, M. Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Autoimmun Rev 2011, 10, 194–200.
   PubMed Web of Science ®Google Scholar
• Watanabe, A., Kodera, M., Sugiura, K., Usuda, T., Tan, E.M., Takasaki, Y., Tomita, Y., Muro, Y. Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 2004, 50, 892–900.
   PubMed Web of Science ®Google Scholar
• Earnshaw, W., Bordwell, B., Marino, C., Rothfield, N. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest 1986, 77, 426–430.
   PubMed Web of Science ®Google Scholar
• Muro, Y., Sugimoto, K., Okazaki, T., Ohashi, M. The heterogeneity of anticentromere antibodies in immunoblotting analysis. J Rheumatol 1990, 17, 1042–1047.
   PubMed Web of Science ®Google Scholar
• Obuse, C., Yang, H., Nozaki, N., Goto, S., Okazaki, T., Yoda, K. Proteomics analysis of the centromere complex from HeLa interphase cells: UV-damaged DNA binding protein 1 (DDB-1) is a component of the CEN-complex, while BMI-1 is transiently co-localized with the centromeric region in interphase. Genes Cells 2004, 9, 105–120.
   PubMed Web of Science ®Google Scholar
• Izuta, H., Ikeno, M., Suzuki, N., Tomonaga, T., Nozaki, N., Obuse, C., Kisu, Y., Goshima, N., Nomura, F., Nomura, N., Yoda, K. Comprehensive analysis of the ICEN (Interphase Centromere Complex) components enriched in the CENP-A chromatin of human cells. Genes Cells 2006, 11, 673–684.
   PubMed Web of Science ®Google Scholar
• Foltz, D.R., Jansen, L.E., Black, B.E., Bailey, A.O., Yates, J.R. 3rd, Cleveland, D.W. The human CENP-A centromeric nucleosome-associated complex. Nat Cell Biol 2006, 8, 458–469.
   PubMed Web of Science ®Google Scholar
• Okada, M., Cheeseman, I.M., Hori, T., Okawa, K., McLeod, I.X., Yates, J.R. 3rd, Desai, A., Fukagawa, T. The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres. Nat Cell Biol 2006, 8, 446–457.
   PubMed Web of Science ®Google Scholar
• Saito, A., Muro, Y., Sugiura, K., Ikeno, M., Yoda, K., Tomita, Y. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis. J Rheumatol 2009, 36, 781–786.
   PubMed Web of Science ®Google Scholar
• Hsu, T.C., Chang, C.H., Lin, M.C., Liu, S.T., Yen, T.J., Tsay, G.J. Anti-CENP-H antibodies in patients with Sjogren’s syndrome. Rheumatol Int 2006, 26, 298–303.
   PubMed Web of Science ®Google Scholar
• Hamdouch, K., Rodríguez, C., Pérez-Venegas, J., Rodríguez, I., Astola, A., Ortiz, M., Yen, T.J., Bennani, M., Valdivia, M.M. Anti-CENPI autoantibodies in scleroderma patients with features of autoimmune liver diseases. Clin Chim Acta 2011, 412, 2267–2271.
   PubMed Web of Science ®Google Scholar
• Takehara, K., Sato, S. The classification of pathogenesis and the development of therapy in systemic sclerosis: the classification of severity and the guideline for treatment (2004). A research project for systemic sclerosis supported by the Ministry of Health, Labour and Welfare of Japan, 2004. (Articles in Japanese).
   Google Scholar
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23, 581–590.
   PubMed Web of Science ®Google Scholar
• LeRoy, E.C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T.A. Jr, Rowell, N., Wollheim, F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15, 202–205.
   PubMed Web of Science ®Google Scholar
• Fujibayashi, T., Sugai, S., Miyasaka, N., Hayashi, Y., Tsubota, K. Revised Japanese criteria for Sjögren’s syndrome (1999): availability and validity. Mod Rheumatol 2004, 14, 425–434.
   PubMedGoogle Scholar
• Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., Winchester, R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25, 1271–1277.
   PubMed Web of Science ®Google Scholar
• Bohan, A., Peter, J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292, 344–347.
   PubMed Web of Science ®Google Scholar
• Bohan, A., Peter, J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292, 403–407.
   PubMed Web of Science ®Google Scholar
• Yoda, K., Kitagawa, K., Masumoto, H., Muro, Y., Okazaki, T. A human centromere protein, CENP-B, has a DNA binding domain containing four potential alpha helices at the NH2 terminus, which is separable from dimerizing activity. J Cell Biol 1992, 119, 1413–1427.
   PubMed Web of Science ®Google Scholar
• Liu, S.T., Hittle, J.C., Jablonski, S.A., Campbell, M.S., Yoda, K., Yen, T.J. Human CENP-I specifies localization of CENP-F, MAD1 and MAD2 to kinetochores and is essential for mitosis. Nat Cell Biol 2003, 5, 341–345.
   PubMed Web of Science ®Google Scholar
• Sugata, N., Munekata, E., Todokoro, K. Characterization of a novel kinetochore protein, CENP-H. J Biol Chem 1999, 274, 27343–27346.
   PubMedGoogle Scholar
• Kakumanu, P., Yamagata, H., Sobel, E.S., Reeves, W.H., Chan, E.K., Satoh, M. Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 2008, 58, 1576–1581.
   PubMedGoogle Scholar
• Backes, C., Kuentzer, J., Lenhof, H.P., Comtesse, N., Meese, E. GraBCas: a bioinformatics tool for score-based prediction of Caspase- and Granzyme B-cleavage sites in protein sequences. Nucleic Acids Res 2005, 33, W208–W213.
   PubMed Web of Science ®Google Scholar
• Whyte, J., Soriano, E., Earnshaw, W.C., McHugh, N.J. Frequency of autoantibodies to a major epitope on the carboxyl terminal fragment of CENP-B in patients with autoimmune disease. Br J Rheumatol 1995, 34, 407–412.
   PubMedGoogle Scholar
• Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W.B., Rosen, A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999, 190, 815–826.
   PubMed Web of Science ®Google Scholar
• Schachna, L., Wigley, F.M., Morris, S., Gelber, A.C., Rosen, A., Casciola-Rosen, L. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss. Arthritis Rheum 2002, 46, 1873–1884.
   PubMedGoogle Scholar
• Dohlman, J.G., Lupas, A., Carson, M. Long charge-rich alpha-helices in systemic autoantigens. Biochem Biophys Res Commun 1993, 195, 686–696.
   PubMed Web of Science ®Google Scholar
• Levine, S.M., Raben, N., Xie, D., Askin, F.B., Tuder, R., Mullins, M., Rosen, A., Casciola-Rosen, L.A. Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum 2007, 56, 2729–2739.
   PubMedGoogle Scholar
• Nozawa, K., Fritzler, M.J., Chan, E.K. Unique and shared features of Golgi complex autoantigens. Autoimmun Rev 2005, 4, 35–41.
   PubMed Web of Science ®Google Scholar
• Qiu, S., Wang, J., Yu, C., He, D. CENP-K and CENP-H may form coiled-coils in the kinetochores. Sci China, C, Life Sci 2009, 52, 352–359.
   PubMedGoogle Scholar
• Tan, E.M., Muro, Y., Pollard, K.M. Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions. Clin Exp Rheumatol 1994, 12 Suppl 1, 27–31.
   Google Scholar
• Ogawa, Y., Sugiura, K., Watanabe, A., Kunimatsu, M., Mishima, M., Tomita, Y., Muro, Y. Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain. J Autoimmun 2004, 23, 221–231.
   PubMed Web of Science ®Google Scholar
• Backes, C., Ludwig, N., Leidinger, P., Harz, C., Hoffmann, J., Keller, A., Meese, E., Lenhof, H.P. Immunogenicity of autoantigens. BMC Genomics 2011, 12, 340.
   PubMed Web of Science ®Google Scholar